i.aspTroClose 1200™ 2.0 Successfully Obtains FDA Certification
In December 2025, the TroClose 1200™ 2.0 was officially granted FDA certification. The TroClose 1200™ series is a globally exclusive Class III innovative medical device product introduced by Lujian Technology from Israel in 2022, and its China market adaptation and technological development were carried out by the Sichuan Innovation CDMO platform.
This product features an innovative semi-ring closure design that enables automated closure of the trocar port. It significantly simplifies the surgical procedure while ensuring consistency and reliability in the closure technique. Evidence from multi-center clinical studies demonstrates that this system effectively reduces post-operative pain and achieves a 0% incidence rate of port hernias, providing strong data support for both the safety and clinical efficacy of the technology.
The FDA certification of TroClose 1200™ 2.0 marks international recognition of Lujian Technology’s R&D and transformation capabilities in the field of high-end minimally invasive surgical instruments, representing a significant step forward in the company's international expansion strategy.
HOME
PRODUCT
PHONE
